Evidence map›Paper›PMID 25535084›Full record

ArticleStem cells (Dayton, Ohio)2015

MicroRNA-199b Modulates Vascular Cell Fate During iPS Cell Differentiation by Targeting the Notch Ligand Jagged1 and Enhancing VEGF Signaling.

Ting Chen, Andriana Margariti, Sophia Kelaini, Amy Cochrane, Shaunta T Guha, Yanhua Hu, Alan W Stitt, Li Zhang, Qingbo Xu

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Signaling pathways and targeted therapy for myocardial infarction.Signal transduction and targeted therapy · 2022
    Review
  10. Article
  11. Hallmarks of exosomes.Future science OA · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Utilization of Human Induced Pluripotent Stem Cells for Cardiac Repair.Frontiers in cell and developmental biology · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ting ChenDepartment of Cardiology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
Andriana Margariti
Sophia Kelaini
Amy Cochrane
Shaunta T Guha
Yanhua Hu
Alan W Stitt
Li Zhang
Qingbo Xu
Queen's University Belfast · GBKing's College London · GBZhejiang University · CN

Funding

British Heart Foundation RG/09/004/27647British Heart Foundation RG/14/6/31144Medical Research Council G0801962
6 · The paper itself

Abstract

aimsRecent ability to derive endothelial cells (ECs) from induced pluripotent stem (iPS) cells holds a great therapeutic potential for personalized medicine and stem cell therapy. We aimed that better understanding of the complex molecular signals that are evoked during iPS cell differentiation toward ECs may allow specific targeting of their activities to enhance cell differentiation and promote tissue regeneration. METHODS AND

resultsIn this study, we have generated mouse iPS cells from fibroblasts using established protocol. When iPS cells were cultivated on type IV mouse collagen-coated dishes in differentiation medium, cell differentiation toward vascular lineages were observed. To study the molecular mechanisms of iPS cell differentiation, we found that miR-199b is involved in EC differentiation. A step-wise increase in expression of miR-199 was detected during EC differentiation. Notably, miR-199b targeted the Notch ligand JAG1, resulting in vascular endothelial growth factor (VEGF) transcriptional activation and secretion through the transcription factor STAT3. Upon shRNA-mediated knockdown of the Notch ligand JAG1, the regulatory effect of miR-199b was ablated and there was robust induction of STAT3 and VEGF during EC differentiation. Knockdown of JAG1 also inhibited miR-199b-mediated inhibition of iPS cell differentiation toward smooth muscle markers. Using the in vitro tube formation assay and implanted Matrigel plugs, in vivo, miR-199b also regulated VEGF expression and angiogenesis.

conclusionsThis study indicates a novel role for miR-199b as a regulator of the phenotypic switch during vascular cell differentiation derived from iPS cells by regulating critical signaling angiogenic responses. Stem Cells 2015;33:1405-1418.

Indexed as

Cell DifferentiationCell LineageAnimalsBlood VesselsCalcium-Binding ProteinsEndothelial CellsInduced Pluripotent Stem CellsIntercellular Signaling Peptides and ProteinsJagged-1 ProteinLigandsMembrane ProteinsMiceMicroRNAsNeovascularization, PhysiologicPhenotypeReceptors, NotchCalcium-Binding ProteinsIntercellular Signaling Peptides and ProteinsJag1 protein, mouseJagged-1 ProteinLigandsMembrane ProteinsMicroRNAsMirn199 microRNA, mouseReceptors, NotchSerrate-Jagged ProteinsSTAT3 Transcription FactorVascular Endothelial Growth Factor AAngiogenesisEndothelial cell differentiationInduced pluripotent stem cellsSignal transductionTissue regeneration

Identifiers

PMID25535084
PMCPMC4737258
OpenAlexW1526166370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.